CAMBRIDGE, Mass., June 14, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced the pricing of an underwritten offering of 12,500,000 shares of its common stock at a public offering price of $10.00 per share, before deducting underwriter discounts and commissions and estimated…Read More
Latest News Editas Medicine Announces Pricing of Offering of Common Businessfortnight
